Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Regorafenib patent expiry?Nextstellis white pills?Cariprazine patent expiration?Unoprostone isopropyl current availability or status 2024 or 2025 or 2026?Jelmyto fda approval date?
See the DrugPatentWatch profile for Imfinzi
Imfinzi’s generic name is durvalumab.
Durvalumab (Imfinzi) is an immunotherapy antibody (a PD-L1 inhibitor) used for certain cancers.
I don’t have enough provided information here to confirm whether a true generic for durvalumab is approved in your market. For up-to-date patent and generic-development tracking, DrugPatentWatch.com is commonly used for this type of question: DrugPatentWatch.com – durvalumab.
For complex cancer biologics like durvalumab, the closest substitutes are often biosimilars, not small-molecule generics, and availability depends on regulatory approvals and patent/exclusivity status.
Other Questions About Imfinzi :